دورية أكاديمية
Simultaneous measurement of 18 steroids in human and mouse serum by liquid chromatography-mass spectrometry without derivatization to profile the classical and alternate pathways of androgen synthesis and metabolism.
العنوان: | Simultaneous measurement of 18 steroids in human and mouse serum by liquid chromatography-mass spectrometry without derivatization to profile the classical and alternate pathways of androgen synthesis and metabolism. |
---|---|
المؤلفون: | Desai R; ANZAC Research Institute, University of Sydney, Sydney, NSW 2139, Australia., Harwood DT; Cawthron Institute, Nelson, New Zealand., Handelsman DJ; ANZAC Research Institute, University of Sydney, Sydney, NSW 2139, Australia. |
المصدر: | Clinical mass spectrometry (Del Mar, Calif.) [Clin Mass Spectrom] 2019 Jan 06; Vol. 11, pp. 42-51. Date of Electronic Publication: 2019 Jan 06 (Print Publication: 2019). |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101697500 Publication Model: eCollection Cited Medium: Internet ISSN: 2376-9998 (Electronic) Linking ISSN: 22138005 NLM ISO Abbreviation: Clin Mass Spectrom Subsets: PubMed not MEDLINE |
أسماء مطبوعة: | Original Publication: [Amsterdam] : Elsevier, [2016]-[2020] |
مستخلص: | Background: The recently identified alternate, or backdoor, pathway of DHT synthesis provides important novel information on androgen biosynthesis beyond the classical pathway. We report a rapid and versatile liquid chromatography-tandem mass spectrometry (LC-MS/MS) method to simultaneously and accurately quantify key steroids in human or mouse serum involved in either the classical or backdoor androgen synthesis pathways. Methods: Serum (200 µL) fortified with isotopically labelled internal standards underwent liquid-liquid extraction (LLE) with MTBE and extracts were analysed on a LC-MS/MS. The targeted steroids for quantification were testosterone (T), dihydrotestosterone (DHT), 5α-androstane-3α,17β-diol (3α diol), 5α-androstane-3β,17β-diol (3β diol), dehydroepiandrosterone (DHEA), androstenedione (A4), androsterone (AD), estradiol (E2), estrone (E1), progesterone (P4), pregnenolone (P5), androstenediol (Adiol), 17-hydroxyprogesterone (17-OHP4) and 17-hydroxypregnenolone (17-OHP5), corticosterone (B), cortisol (F), allopregnanolone (Allo-P5) and dihydroprogesterone (DHP). Results: The limits of quantification (LOQ) were 5 pg/mL for E2 and E1, 25 pg/mL for T, 50 pg/mL for A4 and 0.10 ng/mL for DHT, 17OHP5, P4, P5, AD, Adiol, DHEA, AlloP5 and 0.20 ng/mL for 17OHP4, 3α diol, 3β diol, DHP, 0.25 ng/mL for B and 1 ng/mL for F. Accuracy, precision, reproducibility and recovery were within acceptable limits for bioanalytical method validation. The method is illustrated in human and mouse, male and female serum. Conclusions: The presented method is sufficiently sensitive, specific and reproducible to meet the quality criteria for routine laboratory application for accurate quantitation of 18 steroid concentrations in male and female serum from humans or mice for the purpose of profiling androgen synthesis and metabolism pathways. (Crown Copyright © 2019 Published by Elsevier B.V. on behalf of The Association for Mass Spectrometry: Applications to the Clinical Lab (MSACL).) |
References: | Andrology. 2017 Jul;5(4):725-731. (PMID: 28334510) J Clin Endocrinol Metab. 2014 Dec;99(12):4565-73. (PMID: 25268392) Clin Endocrinol (Oxf). 2014 Nov;81(5):746-53. (PMID: 24645738) Rapid Commun Mass Spectrom. 2007;21(19):3200-6. (PMID: 17764104) J Steroid Biochem Mol Biol. 2010 Aug;121(3-5):481-90. (PMID: 20188832) Trends Endocrinol Metab. 2004 Nov;15(9):432-8. (PMID: 15519890) Arch Pathol Lab Med. 2004 Apr;128(4):469-75. (PMID: 15043485) J Clin Endocrinol Metab. 2013 Oct;98(10):3971-3. (PMID: 24098015) Trends Endocrinol Metab. 2017 Nov;28(11):771-793. (PMID: 29031608) Rapid Commun Mass Spectrom. 2004;18(10):1089-94. (PMID: 15150832) J Pharm Biomed Anal. 2007 Jan 17;43(2):701-7. (PMID: 16959461) Bone. 2014 Dec;69:12-22. (PMID: 25193158) Dev Dyn. 2013 Apr;242(4):320-9. (PMID: 23073980) Mass Spectrom Rev. 2003 Sep-Oct;22(5):318-31. (PMID: 12949917) Proc Natl Acad Sci U S A. 2000 Oct 24;97(22):12256-9. (PMID: 11035809) Endocr Rev. 2017 Jun 1;38(3):220-254. (PMID: 28472278) Clin Chim Acta. 2006 Oct;372(1-2):76-82. (PMID: 16707118) J Biol Chem. 1968 Apr 25;243(8):2012-21. (PMID: 4384673) Pediatrics. 2006 Aug;118(2):753-7. (PMID: 16882833) Eur J Endocrinol. 2016 Jan;174(1):25-32. (PMID: 26586837) Steroids. 2009 Nov;74(12):920-6. (PMID: 19576916) Hum Reprod. 2017 Feb;32(2):418-422. (PMID: 27999117) J Clin Endocrinol Metab. 2005 Nov;90(11):5928-36. (PMID: 16118337) Clin Chem. 2014 Mar;60(3):510-7. (PMID: 24334824) Lancet. 2017 Nov 11;390(10108):2194-2210. (PMID: 28576284) Talanta. 2016 May 1;151:148-156. (PMID: 26946022) J Steroid Biochem Mol Biol. 2017 Jan;165(Pt B):342-355. (PMID: 27531846) Clin Chem. 2003 Jul;49(7):1041-4. (PMID: 12816898) J Clin Endocrinol Metab. 1969 Jun;29(6):866-70. (PMID: 5783587) Clin Biochem. 2016 Sep;49(13-14):989-97. (PMID: 27131495) Anal Chem. 2015 Jul 21;87(14):7180-6. (PMID: 26090565) Clin Chem. 2008 Aug;54(8):1290-7. (PMID: 18556330) J Clin Endocrinol Metab. 2012 Mar;97(3):E367-75. (PMID: 22170725) Clin Biochem. 2005 Apr;38(4):319-27. (PMID: 15766733) Clin Chim Acta. 2009 Nov;409(1-2):78-84. (PMID: 19747904) Exp Clin Endocrinol Diabetes. 2007 Oct;115(9):559-70. (PMID: 17943689) J Chromatogr A. 2013 Oct 18;1312:111-7. (PMID: 24041507) Anal Biochem. 2008 Apr 1;375(1):105-14. (PMID: 18162162) Ann Clin Biochem. 2013 Mar;50(Pt 2):95-107. (PMID: 23431485) J Mass Spectrom. 2013 Sep;48(9):1050-8. (PMID: 24078246) Clin Biochem. 2011 Jan;44(1):77-88. (PMID: 20627096) J Sep Sci. 2011 Oct;34(19):2650-8. (PMID: 21898811) Hum Reprod. 2017 Jun 1;32(6):1147-1150. (PMID: 28453777) Semin Reprod Med. 2012 Oct;30(5):417-26. (PMID: 23044879) J Clin Endocrinol Metab. 2014 Jun;99(6):2061-8. (PMID: 24628549) Clin Chem. 2006 Jan;52(1):120-8. (PMID: 16299050) Rapid Commun Mass Spectrom. 2011 May 15;25(9):1297-307. (PMID: 21488127) J Appl Lab Med. 2016 Nov 1;1(3):294-299. (PMID: 33626843) J Clin Endocrinol Metab. 2007 Feb;92(2):405-13. (PMID: 17090633) Anal Chem. 2003 Jul 1;75(13):3019-30. (PMID: 12964746) Steroids. 1970 Oct;16(4):415-28. (PMID: 5533947) Clin Chim Acta. 2007 Jul;382(1-2):134-7. (PMID: 17462614) J Clin Endocrinol Metab. 2013 Apr;98(4):1376-87. (PMID: 23463657) |
فهرسة مساهمة: | Keywords: 17OHP4, 17-hydroxyprogesterone; 17OHP5, 17hydroxypregnenolone; 3α diol, 5α-androstane-3α17β-diol; 3β diol, 5α-androstane-3β17β-diol; A4, androstenedione; AD, androsterone; APPI, atmospheric pressure photoionization; Adiol, androstenediol; AlloP5, allopregnanolone; Androgen; B, corticosterone; CSP, Charcoal Stripped Plasma; DHEA, dehydroepiandrosterone; DHP, dihydroprogesterone; DHT, dihydrotestosterone; Dihydrotestosterone; E1, estrone; E2, estradiol; F, cortisol; IS, internal standard; LOD, lower limit of detection; LOQ, lower limit of quantification; Liquid chromatography–mass spectrometry; ME, matrix effect; MTBE, methyl tert-butyl ether; NMI, National Measurement Institute; P4, progesterone; P5, pregnenolone; S/N, signal-to-noise ratio; Steroidogenesis; T, testosterone; Testosterone |
تواريخ الأحداث: | Date Created: 20211129 Latest Revision: 20231108 |
رمز التحديث: | 20231215 |
مُعرف محوري في PubMed: | PMC8620903 |
DOI: | 10.1016/j.clinms.2018.12.003 |
PMID: | 34841072 |
قاعدة البيانات: | MEDLINE |
تدمد: | 2376-9998 |
---|---|
DOI: | 10.1016/j.clinms.2018.12.003 |